C12H17N5O4
295.29 g/mol
APIDanger
Entecavir hydrate
CAS209216-23-9
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Entecavir hydrate is the monohydrate form of the antiviral compound entecavir, a synthetic purine nucleoside analogue. It is primarily used as an active pharmaceutical ingredient in the manufacture of medicines.
Pharmaceutical manufacturing ingredientResearch compound for nucleoside analogue studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 209216-23-9
Related Compounds
StrongSame Parent
Entecavir
CAS142217-69-4
pharmaceutical raw material
ReferenceSame Category
Fosgonimeton
CAS2093305-05-4
pharmaceutical raw material
ReferenceSame Category
Finafloxacin
CAS209342-40-5
pharmaceutical raw material
ReferenceSame Category
Finafloxacin hydrochloride
CAS209342-41-6
pharmaceutical raw material
ReferenceSame Category
Selitrectinib
CAS2097002-61-2
pharmaceutical raw material
Safety Reference
Danger
H302Harmful if swallowed
H336May cause drowsiness or dizziness
H351Suspected of causing cancer
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H362May cause harm to breast-fed children
H372Causes damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one;hydrate
InChIKey
YXPVEXCTPGULBZ-WQYNNSOESA-N
SMILES
C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2N=C(NC3=O)N.O
Synonyms (22)
- Entecavir (USP)
- BMS 200475-01
- Baraclud
- Baraclude (TN)
- ENTECAVIR [MART.]
- Entecavir hydrate
- Entecavir hydrate (JAN)
- Entecavir hydrate,Baraclude
- Entecavir monohydrate CRS
- entecavir monohydrate